Fresenius Is Latest To File Denosumab With US FDA

While Henlius Confirms EMA Acceptance Of Its European Prolia/Xgeva Biosimilar Filing

 
• By David Wallace
WHITE OAK, MD - JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images)
Fresenius has filed its denosumab biosimilar in the US • Source: Sarah Silbiger/Getty Images (Sarah Silbiger/Getty Images)

More from Biosimilars

More from Products